I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| smooth muscle cell | 7 studies | 20% ± 5% | |
| pericyte | 6 studies | 17% ± 2% | |
| CD4-positive, alpha-beta T cell | 4 studies | 20% ± 3% | |
| endothelial cell | 4 studies | 23% ± 5% | |
| fibroblast | 4 studies | 25% ± 6% | |
| epithelial cell | 4 studies | 31% ± 14% | |
| natural killer cell | 4 studies | 17% ± 1% | |
| plasmablast | 3 studies | 39% ± 16% | |
| classical monocyte | 3 studies | 21% ± 1% | |
| conventional dendritic cell | 3 studies | 24% ± 5% | |
| non-classical monocyte | 3 studies | 23% ± 7% | |
| ciliated cell | 3 studies | 23% ± 3% | |
| macrophage | 3 studies | 21% ± 2% | |
| CD8-positive, alpha-beta T cell | 3 studies | 21% ± 2% | |
| dendritic cell | 3 studies | 30% ± 3% | |
| basal cell | 3 studies | 23% ± 2% |
